Outside the Box: This is what’s at stake if U.S. drug prices fall — and Europeans don’t pay more

In his State of the Union address, President Trump vowed to bring down prescription drug prices in the U.S., and described lower prices in many other countries for identical drugs as “very, very unfair.”

We don’t know exactly how the Trump administration will proceed. But it is important to understand what opportunities exist, and what is at stake for the discovery of new cures, in rebalancing international drug prices.

High drug prices in the U.S. help pharmaceutical innovators pay the high cost of bringing a new drug to market — over $2 billion each according to multiple independent estimates.

>>> Original Source <<<